Estimated lifetime gained with cancer screening tests: a meta-analysis of randomized clinical trials

M Bretthauer, P Wieszczy, M Løberg… - JAMA Internal …, 2023 - jamanetwork.com
Importance Cancer screening tests are promoted to save life by increasing longevity, but it is
unknown whether people will live longer with commonly used cancer screening tests …

[HTML][HTML] Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial

National Lung Screening Trial Research Team - Journal of Thoracic …, 2019 - Elsevier
Abstract Introduction The National Lung Screening Trial (NLST) randomized high-risk
current and former smokers to three annual screens with either low-dose computed …

Cancer overdiagnosis: a biological challenge and clinical dilemma

S Srivastava, EJ Koay, AD Borowsky… - Nature Reviews …, 2019 - nature.com
For cancer screening to be successful, it should primarily detect cancers with lethal potential
or their precursors early, leading to therapy that reduces mortality and morbidity. Screening …

[PDF][PDF] 中国肺癌筛查与早诊早治指南(2021, 北京)

赫捷, 李霓, 陈万青, 吴宁, 沈洪兵, 江宇, 李江… - 中华肿瘤 …, 2021 - suanfayisheng.com
肺癌是中国发病率和死亡率最高的恶性肿瘤. 筛查与早诊早治是降低人群肺癌死亡率的有效措施
. 制定符合中国国情的肺癌筛查与早诊早治指南, 将极大推进中国肺癌筛查的同质性和优质性 …

Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review

E Sosa, G D'Souza, A Akhtar, M Sur… - CA: a cancer journal …, 2021 - Wiley Online Library
Nonsmall cell lung cancer (NSCLC) is the leading cause of cancer deaths. Lung cancer
screening (LCS) reduces NSCLC mortality; however, a lack of diversity in LCS studies may …

ESR/ERS statement paper on lung cancer screening

HU Kauczor, AM Baird, TG Blum, L Bonomo… - European …, 2020 - Springer
In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …

[HTML][HTML] Quitting smoking at or around diagnosis improves the overall survival of lung cancer patients: a systematic review and meta-analysis

S Caini, M Del Riccio, V Vettori, V Scotti… - Journal of Thoracic …, 2022 - Elsevier
Introduction Lung cancer (LC) remains a disease with poor prognosis despite recent
advances in treatments. Here, we aimed at summarizing the current scientific evidence on …

Screening for lung cancer: CHEST guideline and expert panel report

PJ Mazzone, GA Silvestri, S Patel, JP Kanne… - Chest, 2018 - Elsevier
Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States in the past few years, in large part due to the results of the National Lung …

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

CH Marquette, J Boutros, J Benzaquen… - The Lancet …, 2020 - thelancet.com
Background Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of
eligible individuals. Blood signatures might act as a standalone screening tool, refine the …

[HTML][HTML] Cancer screening recommendations: an international comparison of high income countries

MH Ebell, TN Thai, KJ Royalty - Public health reviews, 2018 - Springer
Background Recommendations regarding cancer screening vary from country to country,
and may also vary within countries depending on the organization making the …